• How did COVID impact clinical governance and quality assurance at your health service?
• How has your organisation measured patient experience of digital health care? Has your organisation learned and changed because of feedback from patients about their experience of digital health care?
• What needs to change to ensure Consumer Advisors / Consumer Representatives can contribute to a robust clinical governance in the expansion of digital health?
• Culture is an important part of clinical governance. How does increasing use of digital health influence culture? In positive ways? In negative ways?
• What opportunities have digital audit systems and data provided around innovating care quality and risk assurance practices?

Panellists: